Literature DB >> 26019227

Body Management: Mesenchymal Stem Cells Control the Internal Regenerator.

Arnold I Caplan1, Robert Hariri2.   

Abstract

UNLABELLED: SummaryIt has been assumed that adult tissues cannot regenerate themselves. With the current understanding that every adult tissue has its own intrinsic progenitor or stem cell, it is now clear that almost all tissues have regenerative potential partially related to their innate turnover dynamics. Moreover, it appears that a separate class of local cells originating as perivascular cells appears to provide regulatory oversight for localized tissue regeneration. The management of this regeneration oversight has a profound influence on the use of specific cells for cell therapies as a health care delivery tool set. The multipotent mesenchymal stem cell (MSC), now renamed the medicinal signaling cell, predominantly arises from pericytes released from broken and inflamed blood vessels and appears to function as both an immunomodulatory and a regeneration mediator. MSCs are being tested for their management capabilities to produce therapeutic outcomes in more than 480 clinical trials for a wide range of clinical conditions. Local MSCs function by managing the body's primary repair and regeneration activities. Supplemental MSCs can be provided from either endogenous or exogenous sources of either allogeneic or autologous origin. This MSC-based therapy has the potential to change how health care is delivered. These medicinal cells are capable of sensing their surroundings. Also, by using its complex signaling circuitry, these cells organize site-specific regenerative responses as if these therapeutic cells were well-programmed modern computers. Given these facts, it appears that we are entering a new age of cellular medicine. SIGNIFICANCE: This report is a perspective from an active scientist and an active entrepreneur and commercial leader. It is neither a comprehensive review nor a narrowly focused treatise. The broad themes and the analogy to the working component of a computer and that of a cell are meant to draw several important scientific principles and health care themes together into the thesis that regenerative medicine is a constant throughout life and its management is the next frontier of health care. Mesenchymal stem cells are used as the central connection in the broad theme, not as multipotent progenitors but rather as an important control element in the natural local regeneration process. ©AlphaMed Press.

Year:  2015        PMID: 26019227      PMCID: PMC4479626          DOI: 10.5966/sctm.2014-0291

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  59 in total

1.  Development. Endothelium--chicken soup for the endoderm.

Authors:  N Bahary; L I Zon
Journal:  Science       Date:  2001-09-27       Impact factor: 47.728

2.  What's in a name?

Authors:  Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

Review 3.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

Review 4.  The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells.

Authors:  Aaron Schindeler; Renjing Liu; David G Little
Journal:  Differentiation       Date:  2008-10-22       Impact factor: 3.880

5.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

6.  PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs.

Authors:  Arnold I Caplan; Diego Correa
Journal:  J Orthop Res       Date:  2011-05-25       Impact factor: 3.494

Review 7.  Molecular and cell isoforms during development.

Authors:  A I Caplan; M Y Fiszman; H M Eppenberger
Journal:  Science       Date:  1983-09-02       Impact factor: 47.728

Review 8.  The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease.

Authors:  C T Noguchi; A N Schechter
Journal:  Blood       Date:  1981-12       Impact factor: 22.113

9.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

Authors:  Yoshinori Miyahara; Noritoshi Nagaya; Masaharu Kataoka; Bobby Yanagawa; Koichi Tanaka; Hiroyuki Hao; Kozo Ishino; Hideyuki Ishida; Tatsuya Shimizu; Kenji Kangawa; Shunji Sano; Teruo Okano; Soichiro Kitamura; Hidezo Mori
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  20 in total

1.  Anti-apoptotic Effects of Human Wharton's Jelly-derived Mesenchymal Stem Cells on Skeletal Muscle Cells Mediated via Secretion of XCL1.

Authors:  SooJin Kwon; Soo Mi Ki; Sang Eon Park; Min-Jeong Kim; Brian Hyung; Na Kyung Lee; Sangmi Shim; Byung-Ok Choi; Duk L Na; Ji Eun Lee; Jong Wook Chang
Journal:  Mol Ther       Date:  2016-06-23       Impact factor: 11.454

2.  Stromal vascular fraction cell therapy for osteoarthritis in elderly: Multicenter case-control study.

Authors:  Jaroslav Michalek; Alena Vrablikova; Adas Darinskas; Ladislav Lukac; Jaroslav Prucha; Josef Skopalik; Jan Travnik; Marek Cibulka; Zuzana Dudasova
Journal:  J Clin Orthop Trauma       Date:  2018-11-23

3.  A Gingiva-Derived Mesenchymal Stem Cell-Laden Porcine Small Intestinal Submucosa Extracellular Matrix Construct Promotes Myomucosal Regeneration of the Tongue.

Authors:  Qilin Xu; Rabie M Shanti; Qunzhou Zhang; Steven B Cannady; Bert W O'Malley; Anh D Le
Journal:  Tissue Eng Part A       Date:  2017-01-04       Impact factor: 3.845

4.  Adhesion, distribution, and migration of differentiated and undifferentiated mesenchymal stem cells (MSCs) seeded on nerve allografts.

Authors:  Femke Mathot; Nadia Rbia; Allen T Bishop; Steven E R Hovius; Andre J Van Wijnen; Alexander Y Shin
Journal:  J Plast Reconstr Aesthet Surg       Date:  2019-05-22       Impact factor: 2.740

Review 5.  Targeted stimulation of MSCs in peripheral nerve repair.

Authors:  Femke Mathot; Alexander Y Shin; Andre J Van Wijnen
Journal:  Gene       Date:  2019-03-05       Impact factor: 3.688

6.  Transcriptomic Analysis of Human Mesenchymal Stem Cell Therapy in Incontinent Rat Injured Urethra.

Authors:  Zhina Sadeghi; Jonathan D Kenyon; Brian Richardson; Ahmad O Khalifa; Michael Cartwright; Britt Conroy; Arnold Caplan; Mark J Cameron; Adonis Hijaz
Journal:  Tissue Eng Part A       Date:  2020-07-02       Impact factor: 3.845

Review 7.  Stem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding.

Authors:  Cosmin Andrei Cismaru; Radu Pirlog; George Adrian Calin; Ioana Berindan-Neagoe
Journal:  Stem Cell Rev Rep       Date:  2022-07-16       Impact factor: 6.692

Review 8.  Recent updates on the biological basis of heterogeneity in bone marrow stromal cells/skeletal stem cells.

Authors:  Deepika Arora; Pamela Gehron Robey
Journal:  Biomater Transl       Date:  2022-03-28

9.  Introducing human adipose-derived mesenchymal stem cells to Avance nerve grafts and NeuraGen nerve guides.

Authors:  Femke Mathot; Nadia Rbia; Roman Thaler; Allen T Bishop; Andre J van Wijnen; Alexander Y Shin
Journal:  J Plast Reconstr Aesthet Surg       Date:  2020-04-11       Impact factor: 2.740

10.  Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.

Authors:  Tatiana Chadid; Andrew Morris; Alexandra Surowiec; Scott Robinson; Maiko Sasaki; Jacques Galipeau; Brian P Pollack; Luke P Brewster
Journal:  J Vasc Surg       Date:  2018-08-10       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.